Physician

Pramod Anand Bhargava, M.D.

According to 2025 Medicare claims, Pramod Bhargava, M.D. (NPI: 1568450534) practices nephrology in the Canton-Massillon, OH market, with the plurality of this provider's patient population coming from Stark, OH. This provider's primary affiliated billing organization is KIDNEY & HYPERTENSION CONSULTANTS, INC. (NPI: 1770524696; TIN: 34-1421578) and primary practice location at 44708-6220. Bhargava is affiliated with the IHC Quality Partners, LLC (ACO ID: A2833), participating under the MSSP model.

Bhargava's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 325 traditional Medicare patients, billed 2,672 HCPCS/CPT codes, and received $161,059 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 1,958 prescription claims across 275 beneficiaries totaling $176,999 in drug costs, led by Farxiga (Dapagliflozin Propanediol). Open Payments data shows 2 records totaling $128. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $262,873 to $161,059. Similarly, Part D prescription costs have moved from a higher plateau to a lower plateau, from $411,215 to $176,999. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	468	14,090	$262,873
2016	528	10,845	$275,408
2017	498	3,685	$235,078
2018	471	2,637	$194,629
2019	445	2,327	$208,061
2020	371	1,914	$188,763
2021	367	1,892	$192,435
2022	273	1,418	$156,980
2023	312	3,758	$232,216
2024	325	2,672	$161,059

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	250	2,874	$411,215
2016	262	2,627	$781,240
2017	235	2,312	$388,477
2018	242	2,214	$831,582
2019	255	2,199	$146,537
2020	264	2,309	$161,968
2021	259	2,070	$153,906
2022	265	2,150	$167,328
2023	268	2,200	$227,001
2024	275	1,958	$176,999

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	64	70	$131
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	76	181	$89
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	74	146	$60
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	54	56	$47
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	108	197	$41

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Farxiga	Dapagliflozin Propanediol	66	2,578	$47,479
Veltassa	Patiromer Calcium Sorbitex	36	1,076	$32,210
Lokelma	Sodium Zirconium Cyclosilicate	38	1,386	$31,274
Sevelamer Carbonate	Sevelamer Carbonate	57	3,920	$9,479
Calcium Acetate	Calcium Acetate	48	1,964	$3,449

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	2	$128	Medtronic, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Pramod Anand Bhargava, M.D.?

Tedicare shows public-source Medicare data for Pramod Anand Bhargava, M.D. (NPI 1568450534), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Pramod Anand Bhargava, M.D. have ACO affiliation data?

Pramod Anand Bhargava, M.D. is shown with ACO affiliation data for IHC Quality Partners, LLC (MSSP, ACO ID A2833).

What billing organization is linked to Pramod Anand Bhargava, M.D.?

Pramod Anand Bhargava, M.D. is linked to KIDNEY & HYPERTENSION CONSULTANTS, INC. (billing NPI 1770524696) in the available physician profile data.

Does Pramod Anand Bhargava, M.D. have Open Payments data?

Pramod Anand Bhargava, M.D. has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.